2022 ACC/AHA coronary revascularization guidelines (Segment 2)

Published on

A discussion of the new controversial ACC/AHA guideline updates, which reduced the level of evidence for CABG as a treatment for CAD patients with three-vessel disease and normal LV function. The panel provides a rebuttal on the benefits of CABG versus medical therapy and the reduction in class designation for CABG, as well as the use of the ISCHEMIA and other similar trials for drawing such comparative evidence conclusions.

The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.

Video Player is loading.
Current Time 0:00
Duration -:-
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Media Error

    An error occurred while trying to load the media. Please, try again later.

    Retrying, please wait

    Try Again

    Other News

    Cards

    • Recent happenings and trends in mitral valve repair (Segment 4)

      Published on

      In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...

      The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.

      Access Now

    • Recent happenings and trends in mitral valve repair (Segment 3)

      Published on

      In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...

      The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.

      Access Now

    • Recent happenings and trends in mitral valve repair (Segment 2)

      Published on

      In this series, Professor Pieter Kappetein, Chief Medical Officer and Vice President of Cardiac Surgery at Medtronic, Dr. Eugene Grossi of New York University, Dr. Robert L. Smith of Baylor Scott & White in Plano, and Dr. Puja Kachroo from Washington University School of Medicine in St. Louis discuss what has changed and is about to change in the treatment of mitral valve patients. Learn more about the importance of MICS procedures, critical step...

      The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.

      Access Now

    "-- SEO4AJAX --" "seo4ajax Access"

    "-- SEO4AJAX --" "Init" {"hubsSlug":"mycvsurgery","regionsSlug":"ww","languagesSlug":"en","newsSlug":"2022-accaha-coronary-revascularization-guidelines-segment-2"}

    "-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mycvsurgery","regionsSlug":"ww","languagesSlug":"en","newsSlug":"2022-accaha-coronary-revascularization-guidelines-segment-2"} 200 "https://campus.meplis.com/mycvsurgery/ww/en/news/2022-accaha-coronary-revascularization-guidelines-segment-2"

    "-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mycvsurgery","regionsSlug":"ww","languagesSlug":"en","newsSlug":"2022-accaha-coronary-revascularization-guidelines-segment-2"} 200 "https://campus.meplis.com/mycvsurgery/ww/en/news/2022-accaha-coronary-revascularization-guidelines-segment-2"

    "-- SEO4AJAX --" "Timeout: " 5 " seconds"

    "-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mycvsurgery/ww/en/news/2022-accaha-coronary-revascularization-guidelines-segment-2"

    "-- SEO4AJAX --" "Bugsnag Called"